• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定与失巢凋亡相关的基因以建立风险模型并预测直肠腺癌的预后和肿瘤微环境。

Identification of anoikis-related genes to develop a risk model and predict the prognosis and tumor microenvironment in rectal adenocarcinoma.

作者信息

Zhao Bing, Tang Xuegui

机构信息

Department of Integrated Traditional and Western Medicine Anorectal, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Anorectal Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Genet. 2025 Aug 18;16:1604541. doi: 10.3389/fgene.2025.1604541. eCollection 2025.

DOI:10.3389/fgene.2025.1604541
PMID:40901678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12399626/
Abstract

BACKGROUND

Rectal adenocarcinoma (READ) is a common malignant tumor. This study aims to establish a risk model based on anoikis-related genes (ARGs) to predict prognosis and the tumor microenvironment in READ.

METHODS

Transcriptomic data and clinical data downloaded from the TCGA and GEO databases were used for differential analysis and Cox regression analysis. An ARGs-based prognostic risk model was constructed for READ. The survival curves and ROC curves were plotted to determine the predictive ability of the model for READ patients. The model was externally validated in the GSE87211 dataset. A nomogram, immune analysis, drug sensitivity analysis, and functional enrichment analysis were also performed to comprehensively validate the model.

RESULTS

The risk model included 6 prognostic genes (ALDH1A1, BRCA1, GSN, KRT17, SCD, and SNCG). Kaplan-Meier curves for the TCGA training cohort (P < 0.0001), testing cohort (P = 0.018), and GSE87211 dataset (P = 0.036) showed better prognoses in the low-risk group. The AUC for 1-year, 3-year, and 5-year overall survival in the TCGA training cohort, testing cohort, and GSE87211 dataset were (0.962, 0.923, 0.956), (0.887, 0.838, 0.833), and (0.73, 0.817, 0.743), respectively. The nomogram showed that the risk score served as an independent predictor of overall survival. Drug sensitivity analysis revealed differences in the IC50 values of OSI-027, PLX-4720, UMI-77, and Sapitinib between the high-risk and low-risk groups. Immune microenvironment analysis suggested distinct differences in immune cells between the two risk groups. Enrichment analysis revealed that these prognostic ARGs were primarily enriched in pathways and biological processes related to tumorigenesis.

CONCLUSION

The risk model of ARGs can effectively predict READ prognosis and provide potential therapeutic targets.

摘要

背景

直肠腺癌(READ)是一种常见的恶性肿瘤。本研究旨在建立一种基于失巢凋亡相关基因(ARGs)的风险模型,以预测READ的预后和肿瘤微环境。

方法

从TCGA和GEO数据库下载的转录组数据和临床数据用于差异分析和Cox回归分析。构建了基于ARGs的READ预后风险模型。绘制生存曲线和ROC曲线以确定该模型对READ患者的预测能力。该模型在GSE87211数据集中进行了外部验证。还进行了列线图、免疫分析、药物敏感性分析和功能富集分析,以全面验证该模型。

结果

风险模型包括6个预后基因(ALDH1A1、BRCA1、GSN、KRT17、SCD和SNCG)。TCGA训练队列(P < 0.0001)、测试队列(P = 0.018)和GSE87211数据集(P = 0.036)的Kaplan-Meier曲线显示,低风险组的预后更好。TCGA训练队列、测试队列和GSE87211数据集中1年、3年和5年总生存率的AUC分别为(0.962、0.923、0.956)、(0.887、0.838、0.833)和(0.73、0.817、0.743)。列线图显示风险评分是总生存的独立预测因子。药物敏感性分析显示,高风险组和低风险组之间OSI-027、PLX-4720、UMI-77和Sapitinib的IC50值存在差异。免疫微环境分析表明,两个风险组之间的免疫细胞存在明显差异。富集分析显示,这些预后ARGs主要富集在与肿瘤发生相关的通路和生物学过程中。

结论

ARGs风险模型可以有效预测READ的预后,并提供潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/eed48f8a21db/fgene-16-1604541-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/6b6a00e4e4cd/fgene-16-1604541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/f9f6aafd8071/fgene-16-1604541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/957bd06d733d/fgene-16-1604541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/a0b4899c5578/fgene-16-1604541-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/5725143492eb/fgene-16-1604541-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/7fb382fcc0ee/fgene-16-1604541-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/a1659bb594ac/fgene-16-1604541-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/63dfa4fd5460/fgene-16-1604541-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/405909ab8cda/fgene-16-1604541-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/5abf2ed30062/fgene-16-1604541-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/77375dd45303/fgene-16-1604541-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/70879907199f/fgene-16-1604541-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/0cc82b425cb6/fgene-16-1604541-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/39f6028c5229/fgene-16-1604541-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/eed48f8a21db/fgene-16-1604541-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/6b6a00e4e4cd/fgene-16-1604541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/f9f6aafd8071/fgene-16-1604541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/957bd06d733d/fgene-16-1604541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/a0b4899c5578/fgene-16-1604541-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/5725143492eb/fgene-16-1604541-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/7fb382fcc0ee/fgene-16-1604541-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/a1659bb594ac/fgene-16-1604541-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/63dfa4fd5460/fgene-16-1604541-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/405909ab8cda/fgene-16-1604541-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/5abf2ed30062/fgene-16-1604541-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/77375dd45303/fgene-16-1604541-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/70879907199f/fgene-16-1604541-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/0cc82b425cb6/fgene-16-1604541-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/39f6028c5229/fgene-16-1604541-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e3b/12399626/eed48f8a21db/fgene-16-1604541-g015.jpg

相似文献

1
Identification of anoikis-related genes to develop a risk model and predict the prognosis and tumor microenvironment in rectal adenocarcinoma.鉴定与失巢凋亡相关的基因以建立风险模型并预测直肠腺癌的预后和肿瘤微环境。
Front Genet. 2025 Aug 18;16:1604541. doi: 10.3389/fgene.2025.1604541. eCollection 2025.
2
Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer.新型失巢凋亡相关基因作为食管癌预后生物标志物及免疫微环境关键决定因素的特征分析
Front Immunol. 2025 Jul 11;16:1599171. doi: 10.3389/fimmu.2025.1599171. eCollection 2025.
3
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
4
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.无锚定相关长非编码 RNA 特征可预测肝细胞癌的预后,并与免疫浸润相关。
Anticancer Drugs. 2024 Jun 1;35(5):466-480. doi: 10.1097/CAD.0000000000001589. Epub 2024 Mar 11.
5
Development and validation of a Log odds of negative lymph nodes/T stage ratio-based prognostic model for gastric cancer.基于阴性淋巴结/肿瘤分期比值的胃癌对数优势预后模型的开发与验证
Front Oncol. 2025 Jun 3;15:1554270. doi: 10.3389/fonc.2025.1554270. eCollection 2025.
6
Prognostic model of lung adenocarcinoma based on disulfidptosis-related genes and analysis of in vitro cell experiments for PPP1R14B in the model.基于二硫键化相关基因的肺腺癌预后模型及模型中PPP1R14B的体外细胞实验分析
Biol Direct. 2025 Jul 1;20(1):74. doi: 10.1186/s13062-025-00662-7.
7
A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies.一种新型的失巢凋亡相关风险模型可预测结直肠癌患者的预后及对不同免疫治疗策略的反应。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10879-10892. doi: 10.1007/s00432-023-04945-2. Epub 2023 Jun 15.
8
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy.基于坏死性凋亡基因构建肺腺癌预后模型及其肿瘤免疫治疗潜力探索
Transl Cancer Res. 2025 May 30;14(5):2563-2579. doi: 10.21037/tcr-24-2165. Epub 2025 May 26.
9
Revelation of prognosis and tumor microenvironment of colorectal cancer based on genes related to antibody-dependent cellular phagocytosis and single-cell landscape.基于抗体依赖性细胞吞噬相关基因和单细胞图谱揭示结直肠癌的预后及肿瘤微环境
Clin Proteomics. 2025 Aug 21;22(1):28. doi: 10.1186/s12014-025-09553-5.
10
SLC3A2 as a key anoikis-related gene for prognosis and tumor microenvironment remodeling in melanoma.SLC3A2作为黑色素瘤预后和肿瘤微环境重塑的关键失巢凋亡相关基因。
Discov Oncol. 2025 Jul 11;16(1):1306. doi: 10.1007/s12672-025-03125-7.

本文引用的文献

1
Over-expression of KRT17 and MDK genes at mRNA levels in urine-exfoliated cells is associated with early non-invasive diagnosis of non-muscle-invasive bladder cancer.尿液脱落细胞中 KRT17 和 MDK 基因 mRNA 水平的过表达与非肌层浸润性膀胱癌的早期无创诊断相关。
Clin Biochem. 2024 Oct;131-132:110808. doi: 10.1016/j.clinbiochem.2024.110808. Epub 2024 Jul 26.
2
Discovery of UMI-77 as a novel Ku70/80 inhibitor sensitizing cancer cells to DNA damaging agents in vitro and in vivo.发现 UMI-77 可作为一种新型 Ku70/80 抑制剂,在体外和体内增强癌细胞对 DNA 损伤剂的敏感性。
Eur J Pharmacol. 2024 Jul 15;975:176647. doi: 10.1016/j.ejphar.2024.176647. Epub 2024 May 15.
3
A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer.
一种新的肿瘤相关中性粒细胞基因特征,可用于预测乳腺癌的预后、肿瘤免疫微环境和治疗反应。
Sci Rep. 2024 Mar 4;14(1):5339. doi: 10.1038/s41598-024-55513-8.
4
TRAF2 decrease promotes the TGF-β-mTORC1 signal in MAFLD-HCC through enhancing AXIN1-mediated Smad7 degradation.TRAF2 下调通过增强 AXIN1 介导的 Smad7 降解促进 MAFLD-HCC 中的 TGF-β-mTORC1 信号。
FASEB J. 2024 Feb 29;38(4):e23491. doi: 10.1096/fj.202302307R.
5
Activated CD4 T cells/Tregs derived immune-metabolism signature provide precise prognosis assessment for gastric cancer and beneficial for treatment option.活化的CD4 T细胞/调节性T细胞衍生的免疫代谢特征可为胃癌提供精确的预后评估,并有助于治疗方案的选择。
Heliyon. 2024 Feb 1;10(3):e25463. doi: 10.1016/j.heliyon.2024.e25463. eCollection 2024 Feb 15.
6
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
7
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.ALDH1A1 通过与 AR 和 RAR 依赖性转录的相互作用,驱动前列腺癌转移和放射抵抗。
Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024.
8
Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma.失巢凋亡相关基因CDKN2A预测甲状腺癌的预后和免疫反应并介导其增殖与迁移。
Transl Oncol. 2024 Feb;40:101873. doi: 10.1016/j.tranon.2023.101873. Epub 2023 Dec 22.
9
Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics.基于多组学的直肠癌放射治疗相关基因与预后靶标研究。
J Transl Med. 2023 Nov 27;21(1):856. doi: 10.1186/s12967-023-04753-9.
10
Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN.通过靶向脂质代谢关键酶 CPT1A、SCD 和 FASN 重新敏化紫杉醇耐药卵巢癌。
Int J Mol Sci. 2023 Nov 19;24(22):16503. doi: 10.3390/ijms242216503.